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Summary: The Tichonov’s theorem for quasi-stationary approximation is considered 
as a basic approach for reduction of dynamical systems with time hierarchy. On the 
basis of previously determined parameters, seven ordinary differential equations of the 
dynamical model of tumor treated by chemotherapy, immunotherapy and siRNA 
infusion are written in a form appropriate to evaluate their terms for model reduction. 
In accordance with the terminology of the Tichonov’s theorem, it is established that 
three of the system components are fast varying such that the corresponding kinetic 
equations form an attached system. The other four variables are slow varying and their 
kinetic equations form a degenerate system 
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1. INTRODUCTION 
 
Mathematical modeling of biological processes with different time 
scales leads to reduction of the governing equations to a quasi-
stationary approximation (QSSA). In this paper, the term QSSA is 
used in a sense explained in the work of Schneider and Wilhelm [1]. 
Model reduction based on this approximation has found various 
applications in systems biology, including studies related to cell 
proliferation, and differentiation and the cell cycle [2]. The current 
work presents a more general approach to a QSSA based on the 
method of Tichonov’s theorem proved in [3]. This is a new insight to 
the theorem and it essence is proposed here together with an 
elementary description of theorem application. Our aim is to 
demonstrate that the application of the method in this new form to 
the problems of tumors can be fruitful. On the other hand, we show 
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that the QSSA theorem proved in the work of Tichonov [3] is very 
original and consistent from the pure mathematical point of view, but 
also effective in a computational sense, independently of the 
widespread time-scale procedure 
 
2. TICHONOV’S THEOREM AS AN APPROACH FOR 
    REDUCTION OF DYNAMICAL SYSTEMS WITH TIME 
    HIERARCHY 
 
Mathematical modeling of biological processes with different time 
scales leads in general to dynamical system in the form: 
) , ( y x f
dt
x d r r r r
= ε  (2.1) 
) , ( y x g
dt
y d r r r
r
=  (2.2) 
where  1 0 , , << < ∈ ∈ ε
n m R y R x
r r
. The Tichonov’s theorem [3] claims 
that 
The solution of the complete system (2.1-2) tends to the solution of 
the degenerate system (2.2) at  0 → ε , if the following conditions are 
satisfied: 
a) There is an isolated equilibrium (steady state) solution of the 
attached system (2.1) (i.e. there is not other solution in its 
neighborhood). 
b) The existing equilibrium solution of the attached system is stable 
for every value of the slow variables  y
r
. 
c) The initial conditions (states) lie in a region of influence (a basin) 
of the equilibrium solution of the attached system. 
d) The solution of the complete system is single-valued and its right 
hand sides are continuous. 
 
It therefore follows that in every concrete case we can find the 
equilibrium solution of the attached system and to replace it in the 
degenerate one. Moreover, we should demonstrate that all 
requirements of the formulated theorem are satisfied. 
Consider in general case the simplest example of two differential 
equations ( 1 , 1 = = n m ) or  y y x x ≡ ≡
r r
, . Then the system (2.1-2) 
takes the form 
) , ( y x f
dt
dx
= ε  (2.3) 
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) , ( y x g
dt
dy
=  (2.4) 
The essence of Tichonov’s theorem claims that the character of the 
solution of system (2.3-2.4) does not change when the small 
parameter ε  tends to zero. Thus we can assume  0 = ε  in (2.3) and 
instead of differential equation obtain algebraic ones for the steady 
state value of fast variable x . 
) , ( 0 y x f =  (2.5) 
) , ( y x g
dt
dy
=  (2.6) 
From the equation (2.5) the fast variable x  can be expressed as a 
function of  , i.e.  y ) (y x ϕ = and substituted in (2.6). As a result (2.6) 
becomes 
 
] ), ( [ y y g
dt
dy
ϕ =  (2.7) 
 
In this way the complete system of two equations (2.3-4) is reduced 
to the degenerate system of one equation (2.7). Moreover the 
stationary values of the fast variable x depend only on the current 
values of the slow variable , but not on final stationary values. In 
this sense the variable   plays role of a driver of the subordinated 
variable 
y
y
x .In accordance with the Tichonov’s theorem, when the 
stationary solution of the attached system is isolated and stable, then 
the solution of the degenerate system depends only on the initial 
values of the slow variables. Therefore, the presence of a small 
parameter is a necessary condition of dimensionality reduction of the 
complete system. A preliminary dimensionless procedure is 
necessary to apply on the corresponding system, however, in order to 
appear such parameter. The last one expresses rather in 
normalization (or scaling) of the terms in the right hand sides of the 
systems equations. In this way only ε  is considered as a 
dimensionless parameter, drawing attention also that it has not any 
physical sense. 
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3. SCALING OF THE DYNAMICAL MODEL OF AGGRESSIVE 
    TUMOR TREATED BY CHEMOTHERAPY, 
    IMMUNOTHERAPY AND SIRNA INFUSION 
 
We consider the dynamical model of aggressive tumor treated by 
chemotherapy, immunotherapy and siRNA infusion developed in [4]. 
The model is presented by the following system of nonlinear 
differential equations: 
RT K TM K TL K TN K T K
dt
dT
5 4 3 2 1 + − − − =  (3.1) 
NM K N K K
dt
dN
8 7 6 − − =  (3.2) 
12 11 10 9 K LI K LM K L K
dt
dL
+ + − − =  (3.3) 
RS K R K T K
dt
dR
15 14 13 − − =  (3.4) 
M D M K
dt
dM
+ − = 16   (3.5) 
IR K D I K
dt
dI
I 18 17 − + − =  (3.6) 
S K D
dt
dS
S 19 − =  (3.7) 
where  and  are state variables presenting dynamics 
of the tumor cell population, the total NK cell effectiveness,  the total 
CD8 + T cell effectiveness,  the total TGF-β cytokines production, 
the chemotherapy  drug concentration, the immunotherapy (IL-2) 
drug concentration and the cytoplasmic free siRNA concentration, 
respectively, and 
I M R L N T , , , , , S
19 1 K K −  are rate constants (parameters) of the 
model. Moreover, the constant doses of chemotherapy, 
immunotherapy and siRNAs drugs are denoted by   and  , 
respectively. In [5-10] the following numerical values for system 
parameters are given: 
I M D D , S D
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day per mg mh D
day per pulse IU D
day per ml mg D
K K K K
K K K
K K K
K K K
K K K
K K K
S
I
M
/ 10 . 125 , 0
; / 10 . 5
; / 10 . 2
; 66 , 0 ; 10 ; 10 ; 9 , 0
; 004 , 0 ; 10 ; 10 . 3
; 10 . 2 , 5 ; 28 , 0 : 42 , 0
; 01 , 0 ; 53 , 0 ; 10 . 08 , 5
; 10 . 82 , 0 ; 10 . 7 , 2 ; 62 , 0
; 10 . 11 , 7 ; 10 . 2 , 5 ; 58 , 0
12
6
6
19
3
18 17 16
15 14
4
13
5
12 11 10
9 8
2
7
4
6
8
5 4
9
3
10
2 1
−
−
−
−
−
−
− −
=
=
=
= = = =
= = =
= = =
= = =
= = =
= = =
 (3.8) 
 
In addition in [7, 9, 10-13] the following stationary values for state 
variables are given: 
 
; / 10 . 5
; / 10 . 5 ; / 10 . 5 , 3
; / 10 ; / 10
; / 10 ; / 10
10
4 * 6 *
8 * 2 *
5 * 8 *
ml mg S
ml mg I ml mg M
ml mg R ml cells L
ml cells N ml cells T
−
− −
−
=
= =
= =
= =
 (3.9) 
 
On the base of above given numerical values (3.9) for the variables 
of the considered system (3.1-3.7), analogically to investigations 
made in [14, 15] we form the following substitutions: 
; ; ;
; ; / ; / ; /
6 3 3
4 3 4
s S i I m M
r R l L n N T
ε ε ε
ε ε ε ε τ
= = =
= = = =
 (3.10) 
Here from (3.9) we select the value ε=0.01 to be characteristic 
dimensionless values of state variables. In this way the new variables 
i m r l n , , , , , τ and  have an order of 1 (i.e. they change in the interval 
between 0.1 and 10). This is in accordance with the principle of non-
dimensionality. In the same way the coefficients (3.8) can be 
expressed in the form: 
s
 
; ; / ; ;
; ; ; ;
; ; ; / ;
; ; ; ; ; /
; ; ; ; ;
6 3 3
19 19
18
2
18 17 17 16 16 15
2
15
14 14 13
2
13
3
12 12 11 11
10 10 9 9 8 8 7 7
2
6 6
5
4
5 4 4 3
5
3 2
5
2 1 1
S S I I M M d D d D d D k K
k K k K k K k K
k K k K k K k K
k K k K k K k K k K
k K k K k K k K k K
ε ε ε
ε ε
ε ε
ε ε ε
ε ε ε
= = = =
= = = =
= = = =
= = = = =
= = = = =
 (3.11) 
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where the new coefficients  S I M i d d d i k , , ), 19 ,..., 2 , 1 ( =  have the same 
order (i.e. they change in the interval between 0.1 and 10). After 
replacing (3.10) and (3.11) in (3.1-3.7) we obtain the following 
system in Tichonov’s form 
 
τ ε τ ε τ ε τ ε τ
τ
r k m k l k n k k
dt
d
5
8
4
3
3
4
2
2
1 + − − − =  (3.12) 
nm k n k k
dt
dn
8
3
7 6 ε ε ε − − =  (3.13) 
12 11
4
10
5
9
3 2 k i l k lm k l k
dt
dl
+ + − − = ε ε ε ε  (3.14) 
rs k r k k
dt
dr
15
9
14
6
13
6 ε ε τ ε − − =  (3.15) 
M d m k
dt
dm
+ − = 16  (3.16) 
ir k d i k
dt
di
I 18
9
17
5 5 ε ε ε − − + − =  (3.17) 
s k d
dt
ds
S 19 − =ε  (3.18) 
 
The presence of a small parameter ε  in every term of this system 
determines its order. This means in accordance with the terminology 
of Tichonov’s theorem we can say that the equations (3.14), (3.15) 
and (3.17) form an attached  system, and the other four form a 
degenerate one. The set of both systems is referred to as the 
complete system. Certainly, Tichonov’s theorem can be applied 
separately to every two groups of equations mentioned. It’s worthy 
to note that the presence of epsilon terms in the right hand sides of 
more of equations does not influence on the order of corresponding 
derivatives in the left hand sides. This is in view of the circumstance 
that they can be just neglected in comparison of the other terms in 
the right sides, when estimating the order of derivatives. These 
considerations are essential for understanding and applying 
Tichonov’s theorem. 
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4. CONCLUSION 
 
The main conclusion from the considerations made in this paper is 
that time hierarchy exists in the dynamical model of aggressive 
tumor treated by combination of three therapies. By appropriate 
scaling of the model mentioned above the small parameter ε is 
derived in its equations. In accordance with terminology of 
Tichonov’s theorem it is established that concentrations of   the 
CD8+ T cells, the TGF-β cytokines and  the immunotherapy  (IL-2) 
drug are fast varying with respect to concentrations of the tumor 
cells, the NK cells, the chemotherapy and the siRNA drugs, which 
are slow varying system components. The separation of fast and slow 
system variables, made here is needed for further application of the 
Tichonov’s theorem, presented in the paper. 
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